Atlas Trials

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

Clinical trial NCT06613113 · RECRUITING

Trial details

NCT number
NCT06613113
Sponsor
Ningbo Medical Center Lihuili Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
MSS Metastatic Colorectal Cancer
Start date
2024-08-07
Primary completion
2025-04-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.